667 | REAL‐WORLD SAFETY AND EFFICACY OF EPCORITAMAB FOR PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMASAllison M. Bock, Saira Ahmed, Lei Feng et al.|Hematological Oncology|2025Cited by 0
Real world outcomes of sequencing bispecific antibodies (BsAb) in patients with relapsed / refractory follicular lymphoma (R/R FL): A multi-center cohort study from cubic consortiumChijioke Nze, Narendranath Epperla, Allison M. Bock et al.|Blood|2025Cited by 0
Consolidation (Cons) and maintenance (Maint) approaches in primary central nervous system lymphoma (PCNSL) after high-dose methotrexate induction in transplant-ineligible patientsYun Kyoung Tiger, Graham T. Wehmeyer, Joshua Friedman et al.|Blood|2025Cited by 0
Evaluation of prognostic factors and survival outcomes in patients with Relapsed/Refractory (R/R) large B-cell lymphomas (LBCLs) treated with epcoritamabAllison M. Bock, Sairah Ahmed, Lei Feng et al.|Blood|2025Cited by 0